Log In
Print
BCIQ
Print
Print this Print this
 

CT-011

  Manage Alerts
Collapse Summary General Information
Company CureTech Ltd.
DescriptionHumanized anti-PD-1 mAb
Molecular Target Programmed cell death 1 (PDCD1) (PD-1) (CD279)
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today